News
BIAF ▼ -15.1% - bioAffinity Technologies, Inc.
BIAF ▼ -15.1% - bioAffinity Technologies, Inc.
$BIAF bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026
13-OCT-2026 08:03 AM ET
Share this post
More filings for $BIAF
BIAF ▼ -16.3% - bioAffinity Technologies, Inc.Oct 10, 2026BIAF ▼ -12.8% - bioAffinity Technologies, Inc.Oct 9, 2026BIAF ▲ +3.4% - bioAffinity Technologies, Inc.Oct 8, 2026BIAF ▲ +16.2% - bioAffinity Technologies, Inc.Oct 8, 2026BIAF ▲ +15.6% - bioAffinity Technologies, Inc.Oct 8, 2026BIAF ▲ +15.6% - bioAffinity Technologies, Inc.Oct 8, 2026
View full $BIAF filing history →💬 Comments
Loading comments…
Leave a comment